Mckinley Capital Management LLC Hutchmed (China) LTD Transaction History

Mckinley Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$17.84 - $22.69 $323,688 - $411,687	-18,144 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$22.0 - $31.78 $82,830 - $119,651	-3,765 Reduced 17.18%	18,144 $399,000
Q1 2019 May 02, 2019	SELL	$21.27 - $30.58 $28,629 - $41,160	-1,346 Reduced 5.79%	21,909 $670,000
Q4 2018 Feb 11, 2019	BUY	$23.09 - $37.69 $28,469 - $46,471	1,233 Added 5.6%	23,255 $537,000
Q3 2018 Nov 08, 2018	SELL	$26.55 - $34.38 $31,860 - $41,256	-1,200 Reduced 5.17%	22,022 $709,000
Q2 2018 Jul 13, 2018	SELL	$27.79 - $34.49 $28,234 - $35,041	-1,016 Reduced 4.19%	23,222 $700,000
Q1 2018 May 04, 2018	SELL	$28.87 - $41.13 $206,738 - $294,531	-7,161 Reduced 22.81%	24,238 $717,000
Q4 2017 Feb 08, 2018	BUY	$27.41 - $39.42 $860,646 - $1.24 Million	31,399	31,399 $1.24 Million

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.91B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mckinley Capital Management LLC with notifications on news.